A 7-year-old boy is brought to the child psychiatry clinic by his mother with complaints of inattention and hyperactivity for the past 18 months. The teacher reports that he frequently interrupts classroom activities, cannot sit still during lessons, and loses his pencils and homework regularly. At home, he fidgets constantly, talks excessively, and has difficulty waiting his turn during family meals. On mental status examination, he is restless, makes poor eye contact, and frequently changes topics mid-conversation. His intelligence quotient is normal. There is no history of seizures, head trauma, or significant medical illness. His father had similar difficulties during childhood. What is the most appropriate first-line pharmacological intervention for this child?

Explanation

## Diagnosis and Management of ADHD in Children ### Clinical Presentation This child meets DSM-5 criteria for Attention-Deficit/Hyperactivity Disorder (ADHD): - **Inattention symptoms:** loses items, forgetfulness, difficulty sustaining attention - **Hyperactivity-impulsivity symptoms:** fidgeting, excessive talking, difficulty waiting turn, interrupting - **Onset:** before age 12 (18 months duration documented) - **Functional impairment:** across multiple settings (school and home) - **Normal intelligence:** excludes intellectual disability - **Family history:** positive (father affected), supporting genetic component ### First-Line Pharmacotherapy **Key Point:** Stimulant medications (methylphenidate and amphetamines) are the gold-standard first-line pharmacological agents for ADHD in children aged 6 years and older. **High-Yield:** Methylphenidate is a selective norepinephrine and dopamine reuptake inhibitor that enhances prefrontal cortex function, improving executive function, attention, and impulse control. | Feature | Methylphenidate | Amphetamine | Non-Stimulants | |---------|-----------------|-------------|----------------| | **Onset of action** | 30–60 min (immediate-release) | 30–60 min | 2–4 weeks | | **Duration** | 3–4 hrs (IR); 8–12 hrs (ER) | 4–6 hrs (IR); 8–12 hrs (ER) | 12–24 hrs | | **First-line status** | Yes | Yes (if methylphenidate fails) | Second-line | | **Common side effects** | Appetite ↓, insomnia, headache | Appetite ↓, insomnia, tachycardia | Sedation, dry mouth | **Clinical Pearl:** Behavioral interventions (parent training, classroom accommodations) should be initiated alongside pharmacotherapy. Stimulants are most effective when combined with psychosocial support. **Mnemonic: ADHD STIM** — Stimulants (methylphenidate, amphetamines) are the Treatment of choice In ADHD Management. ### Monitoring During Treatment 1. Baseline: height, weight, blood pressure, heart rate, ECG (if cardiac risk factors) 2. Titration: start low, increase gradually every 1–2 weeks 3. Follow-up: assess efficacy (teacher/parent rating scales), side effects, growth parameters at 3–6 months **Warning:** Do not use stimulants in children with uncontrolled hypertension, cardiac arrhythmias, or active substance use disorder in adolescents. Screen for cardiac risk factors before initiation. [cite:DSM-5, ICD-11 ADHD diagnostic criteria; Harrison 21e Ch 470]